Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.9M Hold
1,577,580
0.01% 1976
2025
Q4
$42M Hold
1,577,580
0.01% 1804
2025
Q3
$47.9M Hold
1,577,580
0.01% 1669
2025
Q2
$49.5M Hold
1,577,580
0.01% 1538
2025
Q1
$60.3M Hold
1,577,580
0.01% 1318
2024
Q4
$69.2M Hold
1,577,580
0.01% 1180
2024
Q3
$67.9M Hold
1,577,580
0.01% 949
2024
Q2
$71.3M Hold
1,577,580
0.02% 826
2024
Q1
$98.5M Buy
+1,577,580
New +$94.4M 0.02% 653
2017
Q4
Sell
-79,307
Closed -$5.68M 7905
2017
Q3
$5.68M Buy
+79,307
New +$5.52M ﹤0.01% 2091

Other funds holding ENOV

UBS Group's ENOV Position: Q1 2026 in Review

UBS Group increased its Enovis (ENOV) stake by 18% in Q1 2026, buying an estimated $2.92M and bringing the position to 821,906 shares worth $18.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

UBS Group first reported a position in ENOV in Q4 2014 and has held it in 46 quarters since. The position peaked at $38.2M in Q4 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • UBS Group held 821,906 shares of Enovis worth $18.7M as of Q1 2026.
  • UBS Group bought 123,565 Enovis shares in Q1 2026, an estimated $2.92M.
  • Enovis made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2671 holding.
  • UBS Group first reported a position in Enovis in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Enovis position peaked at $38.2M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.